Neumora Therapeutics Announced That Effective February 14, Paul Berns, Neumora's Co-founder And Executive Chair Of The Board Of Directors, Will Transition To CEO And Chairman, And Henry Gosebruch Will Step Down, Michael Milligan Will Serve As CFO